In assisted reproductive therapy, the effectiveness of ovulation induction protocols is directly related to the choice of medications. Drugs such as Gonadotropin Stimulating Hormone, Pergonal, and Urinary Follicle Stimulating Hormone... different names often confuse patients: what are the differences in prices and effects? Is the more expensive drug necessarily better for them?

In fact, the core function of all ovulation induction drugs is to promote follicle development. However, their ingredients, purity levels, and duration of action vary, and so do the groups of people who can benefit from them. The key when choosing a drug isn't about "the more expensive, the better," but rather about finding a drug that accurately matches the patient's ovarian response and treatment goals.

1. Core components and classification of ovulation induction drugs

The core active ingredient in ovulation induction drugs is Follicle Stimulating Hormone (FSH). Some formulations also contain Luteinizing Hormone (LH) activity, allowing them to simulate the hormonal environment of the natural cycle and promote the synchronized development of multiple follicles.
The main differences between various formulations lie in four aspects:Source of the drug, purity level, half-life, and method of administration2. Classification by source:Recombinant FSH vs. Urinary FSH/HMG

1. Recombinant FSH formulations

Representative drugs like Gonadotropin Stimulating Hormone and Pergonal are high-purity FSH preparations obtained through recombinant DNA technology.

• Key features: The drug has extremely high purity, consistent ingredients across batches, precise dosage markings, allowing for fine-tuning; administration is typically subcutaneous injection, which is convenient and painless.
• Advantages: High purity, consistent quality, precise dosing, convenient administration.

2. Urodrenalin-based FSH/HMG Products

Representative drugs like urodrenalin (HMG) are purified gonadotropins extracted from the urine of postmenopausal women. In addition to FSH, these drugs also contain a small amount of natural LH activity.

• : The price is significantly lower than that of recombinant products, making this drug highly cost-effective. The natural LH content in these drugs makes them particularly useful for patients with low ovarian response. Due to manufacturing processes, there may be slight differences in purity between batches. The usual administration method is intramuscular injection.
• : These products are affordable and are commonly used in primary care settings and for basic ovulation induction treatments.
• : Suitable for patients with low ovarian reserve or those who have had poor responses in previous treatments. These products are also suitable for patients who are concerned about treatment costs and prioritize cost-effectiveness.

1. Short-acting Ovulation Induction Products

In most cases, conventional ovulation-stimulating medications are administered in short-acting forms, requiring daily injections.

• Key advantages: Flexible dosage adjustment allows doctors to adjust the medication amount based on follicle development and hormone levels during follow-up visits, enabling precise control of ovarian response. The medication is quickly metabolized, so any adverse reactions can be resolved easily after stopping the medication.
• Precautions: Daily injections require high compliance from patients. Those who need to seek medical treatment elsewhere or have busy schedules may need to visit the hospital frequently.

2. Long-acting ovulation-stimulating agents

After a single administration of a long-acting agent, the effect can last for about a week, significantly reducing the number of injections required.

• Key advantages: Reduces the frequency of injections, thereby reducing the psychological burden and operational difficulties for patients. This approach is particularly suitable for those who fear injections, those who cannot travel frequently for medical treatment, or those who have busy daily routines and cannot attend follow-up visits regularly.
• Precautions: Due to the continuous release of the drug, the flexibility of dosage adjustment is less than that of short-acting medications. If there are abnormal ovarian responses, the drug's metabolism will be slower, meaning that intervention may be delayed.

IV. Key principle for selecting medications: Individualization is crucial

There is no absolute "best" solution for ovulation-stimulating medications. The belief that "the more expensive the medication, the better it is" is a common misconception. When choosing medications, doctors consider various factors such as the woman's age, AMH level, number of primordial follicles, previous response to ovulation-stimulating treatments, and ovarian reserve. They then develop a personalized treatment plan.

1. What is the target number of eggs desired for this cycle? What is the expected outcome of the current treatment plan?
2. If excessive or insufficient ovarian response occurs during treatment, what adjustments can be made to the treatment plan?

V. Important Precautions During Treatment

Ovulation-stimulating medications are prescription reproductive hormones, and their use follows strict clinical guidelines:

• It is strictly prohibited to adjust the dosage, change the injection schedule, or stop taking the medication without permission. Any adjustments must be approved by the attending physician.
• It is unnecessary to compare dosages with other patients. The dosage of ovulation-stimulating medications is individualized based on factors such as body weight, ovarian reserve, and baseline hormone levels. The dosage does not reflect the effectiveness of the treatment; comparing dosages blindly only causes unnecessary anxiety.
• It is important to follow the doctor's instructions and have regular check-ups to monitor follicle and hormone levels. This provides accurate information for the doctor to adjust the treatment plan accordingly.

Ovulation stimulation is a highly individualized process in assisted reproduction. The key principle is to choose the most suitable medication for each individual. Whether the medication is imported or domestic, short-acting or long-acting, only a treatment plan that fits the patient's physical conditions and treatment goals will be effective. It is recommended that patients trust professional evaluations and follow the doctor's instructions to complete the treatment cycle smoothly, avoiding unnecessary psychological burdens caused by misinformation.